Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
J Cardiovasc Electrophysiol. 2012 Feb;23(2):130-6. doi: 10.1111/j.1540-8167.2011.02166.x. Epub 2011 Sep 13.
Selective ipsilateral pulmonary vein isolation (SIPVI) has shown comparable efficacy in focal triggered atrial fibrillation (AF) versus isolation of all pulmonary veins (PVs), yet the sufficiency for such an ablation strategy to all patients is unclear. This study sought to identify a subgroup of patients for SIPVI and a subgroup of patients for bilateral PV isolation (BiPVI) with long-term success by comparing the clinical efficacy of SIPVI and BiPVI on PV-triggered AF.
One hundred and forty-two patients (106 males; mean age 51 ± 13 years) with focal PV triggered paroxysmal AF (PAF) were studied. Seventy patients underwent SIPVI and 72 patients underwent BiPVI. After the first ablation, 44 patients (44/70) in the SIPVI group and 54 patients (54/72) in the BiPVI group were free of AF without antiarrhythmic drugs, after a follow-up period of 36 ± 12 months (log-rank test P = 0.1594). In patients younger than 50 years of age with a left atrium (LA) diameter <40 mm, SIPVI had a high success rate (15/18, 83%) of freedom from AF. However, for patients aged ≥50 years with an LA diameter ≥40 mm, 10 of the 12 patients in the SIPVI group and only 5 of the 15 patients in the BiPVI group had a recurrence of AF (log-rank test P = 0.0173).
For focally triggered PAF, in patients aged <50 years with an LA diameter <40 mm, SIPVI of triggering PV had a high success rate of freedom from AF. However, in patients aged ≥50 years with an LA diameter ≥40 mm, BiPVI achieved a higher success rate.
选择性同侧肺静脉隔离(SIPVI)在局灶性触发的心房颤动(AF)中与所有肺静脉(PV)隔离的疗效相当,但对于所有患者来说,这种消融策略是否足够有效尚不清楚。本研究旨在通过比较 SIPVI 和双侧肺静脉隔离(BiPVI)对 PV 触发的 AF 的临床疗效,确定 SIPVI 和 BiPVI 的长期成功的患者亚组。
研究了 142 名(106 名男性;平均年龄 51 ± 13 岁)患有局灶性 PV 触发阵发性 AF(PAF)的患者。70 名患者接受 SIPVI,72 名患者接受 BiPVI。第一次消融后,SIPVI 组 44 名(44/70)和 BiPVI 组 54 名(54/72)患者在 36 ± 12 个月的随访期内无抗心律失常药物的 AF 发作(对数秩检验 P = 0.1594)。在年龄小于 50 岁且左心房(LA)直径<40mm 的患者中,SIPVI 的 AF 无发作率较高(15/18,83%)。然而,对于年龄≥50 岁且 LA 直径≥40mm 的患者,SIPVI 组 12 名患者中有 10 名和 BiPVI 组 15 名患者中有 5 名出现 AF 复发(对数秩检验 P = 0.0173)。
对于局灶性触发的 PAF,在年龄小于 50 岁且 LA 直径<40mm 的患者中,触发 PV 的 SIPVI 无 AF 发作的成功率较高。然而,对于年龄≥50 岁且 LA 直径≥40mm 的患者,BiPVI 的成功率更高。